SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?


To: bob beck who wrote (4101)12/26/2000 6:31:28 PM
From: MGV  Read Replies (1) | Respond to of 4140
 
SNRS now under 2 at a new 52 week low on nearly double average volume. The kind of competition that VISX is alluding to is not good for companies in this industry.



To: bob beck who wrote (4101)4/1/2001 11:57:55 AM
From: MGV  Respond to of 4140
 
Too bad you can't enjoy your own pomposity. You would have much more to enjoy. Just one question - Are you frequently as wrong as you have been about this stock? Never mind - Of course the answer must be "No."

Here is your example. In the 100 day chart, notice the radical divergence between EYE and SNRS in the months from the time you posted your last unperceptive point here. (Disclosure - Own neither EYE nor SNRS.)
100 months
siliconinvestor.com
100 days
siliconinvestor.com



To: bob beck who wrote (4101)4/13/2001 1:15:16 PM
From: MGV  Respond to of 4140
 
You disappeared, rather predictably.

Message 15595029



To: bob beck who wrote (4101)3/27/2002 1:58:25 PM
From: MGV  Respond to of 4140
 
Sunrise Technologies Reduces Staff
FREMONT, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Sunrise Technologies International Inc. (SNRS) announced today it has laid off nearly all of its employees while it continues to search for new financing.

"We had to take this step in order to conserve what is left of our cash. We are continuing discussions with funding sources. If we are successful we plan to bring at least some of these employees back to Sunrise. If the company is not successful in obtaining new funding soon, we will be unable to continue our business operations," said John Hendrick, President and Chief Executive Officer of Sunrise Technologies International, Inc.

Sunrise Technologies International, Inc. is a refractive surgery company based in Fremont, California, that has developed holmium: YAG laser-based systems that utilize a patented process for shrinking collagen developed by Dr. Bruce Sand (the "Sand Process") in correcting ophthalmic refractive conditions.

Except for historical information, this news release contains certain forward-looking statements that involve risk and uncertainties, which may cause actual results to differ materially from the statements made including market potential, regulatory clearances, business growth, and other risks listed from time to time in the Company's Securities and Exchange Commission (SEC) filings. These forward-looking statements represent the Company's judgment, as of the date of this release, and the Company disclaims any intent or obligation to update these forward-looking statements.

Internet users can access Sunrise's World Wide Web site at sunrise-tech.com.

MAKE YOUR OPINION COUNT - Click Here

tbutton.prnewswire.com

SOURCE Sunrise Technologies International, Inc.

CO: Sunrise Technologies International, Inc.

ST: California

IN: MTC

SU: RCN

02/19/2002 15:51 EST prnewswire.com